Table 2 Characteristic of patients demographic

Age (years)

15

11.1 (0.6–17)

Race

8

 Caucasian

2 (25%)

 African American

6 (75%)

Sex

9

 Male

2 (22.2%)

 Female

7 (77.8%)

BMI

6

22.8 (11.2–31)

Comorbid diseases

5

 Edwards syndrome

1 (20%)

 Diabetes

1 (20%)

 Hypertension

1 (20%)

 Obese

2 (40%)

First symptom onset (days)

8

10 (2-27)

 Antibody

1

  Positive

1 (100%)

 Nasopharyngeal PCR

9

  Positive

7 (77.8%)

 Lab parameters

Reference range

  Hemoglobin, g/dL

7

10.6 (8.8–12.2)

10–15.5

  Hematocrit, %

7

31.7 (28.8–39.6)

32–44

  Platelets, ×10³ cells per μL

7

252.3 (111–296)

150–400

  White blood cell count, ×10³ cells per mm³

7

19 (9.3–32.6)

5–10

  Lymphocytes, %

7

11.5 (0.79–58)

20–40

  Absolute neutrophil count (K/mm³)

6

62.8 (28–95)

55–70

  Urea, mg/dL

6

61.3 (23–122)

5–18

  Creatinine, mg/dL

6

0.9 (0.26–1.87)

0.5–1.0

  D-dimer, ng/mL

6

2532.4 (11.5–2324)

<250

  Troponin T, ng/mL

6

0.1 (0.002–0.3)

<0.1

  Creatine kinase myocardial band, ng/mL

5

5.76 (0.64–30.7)

0.1–2.88

  Creatine kinase, U/L

5

96 (50–1008)

<167

  Fibrinogen, mg/dL

5

356 (111–513)

200–393

  aPTT, s

4

39.05 (36–57.9)

25.4–38.9

  Ferritin, ng/mL

4

707 (159–1501)

20–200

  Triglycerides, mg/dL

5

183.5 (59–272)

100–129

  Interleukin-6, pg/mL

1

4105

0.2–7.8

  Blood pH

1

7.2

7.35–7.45

  Bicarbonate, mEq/L

1

15.7

21·0–28·0

  PaCO₂, mm Hg

1

41

35–45

  PaO₂, mm Hg

1

60

80–90

  ScvO₂, %

1

87.2

60–85

  Lactate, mg/dL

6

28 (14–39)

4.5–14.4

  C-reactive protein, mg/L

7

134.1 (1.5–266.6)

<10

  Erythrocyte sedimentation rate (mm/h)

1

74

<10

  Total protein, g/dL

2

6.1 (5–7.2)

6–8

  Albumin, g/dL

7

3 (2.5–4.3)

3.8–5.4

  Total bilirubin, mg/dL

6

3.04 (0.3–11.1)

0.3–1

  Direct bilirubin, mg/dL

5

0.37 (0.23–9.84)

<0.2

  Aspartate aminotransferase, U/L

7

155.9 (20–506)

10–50

  Alanine aminotransferase, U/L

7

142.1 (13–376)

4–36

  Gamma-glutamyl transferase, U/L

6

217.5 (9–479)

5–27